UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 160 filers reported holding UNIQURE NV in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $83,875 | +2.3% | 12,500 | +371.7% | 0.00% | -33.3% |
| Q2 2021 | $82,000 | +115.8% | 2,650 | +152.4% | 0.00% | +50.0% |
| Q4 2020 | $38,000 | +660.0% | 1,050 | +1515.4% | 0.00% | – |
| Q3 2019 | $5,000 | 0.0% | 65 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | +25.0% | 65 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | -78.9% | 65 | -90.0% | 0.00% | -100.0% |
| Q4 2018 | $19,000 | -88.3% | 647 | -85.6% | 0.00% | -83.3% |
| Q3 2018 | $163,000 | +14.0% | 4,484 | 0.0% | 0.01% | +9.1% |
| Q2 2018 | $143,000 | +34.9% | 4,484 | -0.5% | 0.01% | +37.5% |
| Q1 2018 | $106,000 | +324.0% | 4,505 | +253.3% | 0.01% | +300.0% |
| Q4 2017 | $25,000 | – | 1,275 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |